The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for ...

A migraine episode may have up to four distinct stages or phases, each of varying duration: prodrome, aura, headache, and postdrome. However, not everyone experiences all four stages each time.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

Phantom smells (phantosmia) are a rare type of migraine aura. Aura often causes problems with vision and happens before the headache phase of a migraine attack. However, aura can also cause a person ...

Most people with migraine-- about 70%-75% -- get migraine without aura. That usually comes with the things most associated with the disorder: head pain, nausea, and sensitivity to light and sound.

Discover the real causes behind migraines, expert-backed treatment options, and effective strategies to prevent and manage migraine attacks.

Women taking the beta blocker propranolol to ward off migraines have a lower risk of strokes caused by blood clots, according ...

Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines, may lower ischemic stroke risk in women who experience migraines frequently.

The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.